Goldman Sachs Group Inc Biomea Fusion, Inc. Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 102,493 shares of BMEA stock, worth $161,938. This represents 0.0% of its overall portfolio holdings.

Number of Shares
102,493
Previous 102,493 -0.0%
Holding current value
$161,938
Previous $218,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$2.13 - $4.48 $3,062 - $6,442
-1,438 Reduced 1.38%
102,493 $218,000
Q4 2024

Feb 11, 2025
BUY
$3.88 - $12.41 $7,348 - $23,504
1,894 Added 1.86%
103,931 $403,000
Q3 2024

Nov 14, 2024
BUY
$4.23 - $10.1 $14,695 - $35,087
3,474 Added 3.52%
102,037 $1.03 Million
Q2 2024

Aug 13, 2024
SELL
$4.14 - $15.3 $1.03 Million - $3.82 Million
-249,401 Reduced 71.67%
98,563 $443,000
Q1 2024

May 15, 2024
BUY
$13.92 - $19.5 $2.45 Million - $3.43 Million
176,076 Added 102.44%
347,964 $5.2 Million
Q4 2023

Feb 13, 2024
BUY
$8.37 - $19.8 $636,446 - $1.51 Million
76,039 Added 79.33%
171,888 $2.5 Million
Q3 2023

May 14, 2024
SELL
$13.44 - $23.02 $1.02 Million - $1.75 Million
-76,039 Reduced 44.24%
95,849 $1.32 Million
Q3 2023

Nov 14, 2023
SELL
$13.44 - $23.02 $41,677 - $71,385
-3,101 Reduced 3.13%
95,849 $1.32 Million
Q2 2023

May 14, 2024
BUY
$21.66 - $41.8 $73,817 - $142,454
3,408 Added 3.57%
98,950 $2.17 Million
Q2 2023

Aug 14, 2023
BUY
$21.66 - $41.8 $73,817 - $142,454
3,408 Added 3.57%
98,950 $2.17 Million
Q1 2023

May 14, 2024
BUY
$6.8 - $32.35 $422,484 - $2.01 Million
62,130 Added 185.95%
95,542 $2.96 Million
Q1 2023

May 11, 2023
BUY
$6.8 - $32.35 $422,484 - $2.01 Million
62,130 Added 185.95%
95,542 $2.96 Million
Q4 2022

May 14, 2024
BUY
$6.3 - $11.6 $88,559 - $163,061
14,057 Added 72.63%
33,412 $281,000
Q4 2022

Feb 13, 2023
BUY
$6.3 - $11.6 $88,559 - $163,061
14,057 Added 72.63%
33,412 $281,000
Q3 2022

May 14, 2024
BUY
$9.51 - $13.61 $10,641 - $15,229
1,119 Added 6.14%
19,355 $189,000
Q3 2022

Nov 10, 2022
BUY
$9.51 - $13.61 $10,641 - $15,229
1,119 Added 6.14%
19,355 $189,000
Q2 2022

May 14, 2024
SELL
$3.0 - $12.03 $460,956 - $1.85 Million
-153,652 Reduced 89.39%
18,236 $218,000
Q2 2022

Aug 15, 2022
SELL
$3.0 - $12.03 $22,653 - $90,838
-7,551 Reduced 29.28%
18,236 $218,000
Q1 2022

May 16, 2022
BUY
$4.39 - $9.03 $25,694 - $52,852
5,853 Added 29.36%
25,787 $115,000
Q4 2021

Feb 14, 2022
BUY
$7.22 - $12.72 $143,923 - $253,560
19,934 New
19,934 $149,000

Others Institutions Holding BMEA

# of Institutions
107
Shares Held
15.8M
Call Options Held
229K
Put Options Held
354K
View Full List

About Biomea Fusion, Inc.

BMEA Quotes by TradingView
  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $46.3M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email